Erratum: Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22- independent pathways affecting BCR regulation and B cell survival (European Journal of Immunology (2005) vol. 35 (12) (3714) 10.1002/eji.200535247);Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival

European Journal of Immunology

Volumn 35, Issue 12, 2005, Pages 3655-3663

  Ferry, Helen ^a   Cockford, Tanya L ^a   Silver, Karlee ^a   Rust, Nigel ^b   Goodnow, Christopher C ^c   Cornall, Richard ^a  

^a Henry Wellcome Building of Molecular Physiology ^*  (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

B lymphocytes; CD22; Lyn; Lysozyme; Transgene

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD22 ANTIGEN; EGG PROTEIN; IMMUNOGLOBULIN; LYSOZYME; PROTEIN KINASE LYN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; IN VIVO STUDY; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SIGNAL TRANSDUCTION; TRANSGENE;

EID: 29744458161     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.255590598     Document Type: Erratum

References (57)

1. Healy, J. I. and Goodnow, C. C., Positive versus negative signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 1998. 16: 645-670.
2. Niiro, H. and Clark, E. A., Regulation of B-cell fate by antigen-receptor signals. Nat. Rev. Immunol. 2002. 2: 945-956.
3. Tedder, T. F., Tuscano, J., Sato, S. and Kehrl, J. H., CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu. Rev. Immunol. 1997. 15: 481-504.
4. Erickson, L. D., Tygrett, L. T., Bhatia, S. K., Grabstein, K. H. and Waldschmidt, T. J., Differential expression of CD22 (Lyb8) on murine B cells. Int. Immunol. 1996. 8: 1121-1129.
5. Law, C. L., Aruffo, A., Chandran, K. A., Doty, R. T. and Clark, E. A., Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells. J. Immunol. 1995. 155: 3368-3376.
6. Wilson, G. L., Fox, C. H., Fauci, A. S. and Kehrl, J. H., cDNA cloning of the B cell membrane protein CD22: a mediator of B-B cell interactions. J. Exp. Med. 1991. 173: 137-146.
7. Engel, P., Nojima, Y., Rothstein, D., Zhou, L. J., Wilson, G. L., Kehrl, J. H. and Tedder, T. F., The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes. J. Immunol. 1993. 150: 4719-4732.
8. Sgroi, D., Varki, A., Braesch-Andersen, S. and Stamenkovic, I., CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin. J. Biol. Chem. 1993. 268: 7011-7018.
9. Stamenkovic, I. and Seed, B., The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion. Nature 1990. 345: 74-77.
10. Kelm, S., Pelz, A., Schauer, R., Filbin, M. T., Tang, S., de Bellard, M. E., Schnaar, R. L. et al., Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr. Biol. 1994. 4: 965-972.
11. Schulte, R. J., Campbell, M. A., Fischer, W. H. and Sefton, B. M., Tyrosine phosphorylation of CD22 during B cell activation. Science 1992. 258: 1001-1004.
12. Peaker, C. J. and Neuberger, M. S., Association of CD22 with the B cell antigen receptor. Eur. J. Immunol. 1993. 23: 1358-1363.
13. Stamenkovic, I., Sgroi, D., Aruffo, A., Sy, M. S. and Anderson, T., The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells. Cell 1991. 66: 1133-1144.
14. Pflugh, D. L., Maher, S. E. and Bothwell, A. L., Ly-6 superfamily members Ly-6A/E, Ly-6C, and Ly-61 recognize two potential ligands expressed by B lymphocytes. J. Immunol. 2002. 169: 5130-5136.
15. Cyster, J. G. and Goodnow, C. C., Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment. Immunity 1997. 6: 509-517.
16. Doody, G. M., Justement, L. B., Delibrias, C. C., Matthews, R. J., Lin, J., Thomas, M. L. and Fearon, D. T., A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 1995. 269: 242-244.
17. Campbell, M. A. and Klinman, N. R., Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C. Eur. J. Immunol. 1995. 25: 1573-1579.
18. Law, C. L., Sidorenko, S. P., Chandran, K. A., Zhao, Z., Shen, S. H., Fischer, E. H. and Clark, E. A., CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation. J. Exp. Med. 1996. 183: 547-560.
19. Yohannan, J., Wienands, J., Coggeshall, K. M. and Justement, L. B., Analysis of tyrosine phosphorylation-dependent interactions between stimulatory effector proteins and the B cell co-receptor CD22. J. Biol. Chem. 1999. 274: 18769-18776.
20. O'Keefe, T. L., William, G. T., Davies, S. L. and Neuberger, M. S., Hyperresponsive B cells in CD22-deficient mice. Science 1996. 274: 798-801.
21. Sato, S., Miller, A. S., Inaoki, M., Bock, C. B., Jansen, P. J., Tang, M. L. and Tedder, T. F., CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 1996. 5: 551-562.
22. Otipoby, K. L., Andersson, K. B., Draves, K. E., Klaus, S. J., Farr, A. G., Kerner, J. D., Perlmutter, R. M. et al., CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 1996. 384: 634-637.
23. Nitschke, L., Carsetti, R., Ocker, B., Kohler, G. and Lamers, M. C., CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 1997. 7: 133-143.
24. Nishizumi, H., Taniuchi, I., Yamanashi, Y., Kitamura, D., Ilic, D., Mori, S., Watanabe, T. and Yamamoto, T., Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 1995. 3: 549-560.
25. Cyster, J. G. and Goodnow, C. C., Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 1995. 2: 13-24.
26. Hibbs, M. L., Tarlinton, D. M., Armes, J., Grail, D., Hodgson, G., Maglitto, R., Stacker, S. A. and Dunn, A. R., Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 1995. 83: 301-311.
27. Cornall, R. J., Cyster, J. G., Hibbs, M. L., Dunn, A. R., Otipoby, K. L., Clark, E. A. and Goodnow, C. C., Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 1998. 8: 497-508.
28. Chan, V. W., Lowell, C. A. and DeFranco, A. L., Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes. Curr. Biol. 1998. 8: 545-553.
29. Smith, K. G., Tarlinton, D. M., Doody, G. M., Hibbs, M. L. and Fearon, D. T., Inhibition of the B cell by CD22: a requirement for Lyn. J. Exp. Med. 1998. 187: 807-811.
30. Chen, J., McLean, P. A., Neel, B. G., Okunade, G., Shull, G. E. and Wortis, H. H., CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity. Nat. Immunol. 2004. 5: 651-657.
31. Shultz, L. D., Coman, D. R., Bailey, C. L., Beamer, W. G. and Sidman, C. L., "Viable motheaten," a new allele at the motheaten locus. I. Pathology. Am. J. Pathol. 1984. 116: 179-192.
32. O'Keefe, T. L., Williams, G. T., Batista, F. D. and Neuberger, M. S., Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 1999. 189: 1307-1313.
33. Leprince, C., Draves, K. E., Geahlen, R. L., Ledbetter, J. A. and Clark, E. A., CD22 associates with the human surface IgM-B-cell antigen receptor complex. Proc. Natl. Acad. Sci. USA 1993. 90: 3236-3240.
34. Tuscano, J. M., Engel, P., Tedder, T. F., Agarwal, A. and Kehrl, J. H., Involvement of p72syk kinase, p53/56lyn kinase and phosphatidyl inositol-3 kinase in signal transduction via the human B lymphocyte antigen CD22. Eur. J. Immunol. 1996. 26: 1246-1252.
35. Tooze, R. M., Doody, G. M. and Fearon, D. T., Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin. Immunity 1997. 7: 59-67.
36. Pezzutto, A., Dorken, B., Moldenhauer, G. and Clark, E. A., Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140. J. Immunol. 1987. 138: 98-103.
37. Pezzutto, A., Rabinovitch, P. S., Dorken, B., Moldenhauer, G. and Clark, E. A., Role of the CD22 human B cell antigen in B cell triggering by anti-immunoglobulin. J. Immunol. 1988. 140: 1791-1795.
38. Tuscano, J., Engel, P., Tedder, T. F. and Kehrl, J. H., Engagement of the adhesion receptor CD22 triggers a potent stimulatory signal for B cells and blocking CD22/CD22L interactions impairs T-cell proliferation. Blood 1996. 87: 4723-4730.
39. Poe, J. C., Fujimoto, Y., Hasegawa, M., Haas, K. M., Miller, A. S., Sanford, I. G., Bock, C. B. et al., CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nat. Immunol. 2004. 5: 1078-1087.
40. Xu, Y., Harder, K. W., Huntington, N. D., Hibbs, M. L. and Tarlinton, D. M., Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 2005. 22: 9-18.
41. Gauld, S. B., Dal Porto, J. M. and Cambier, J. C., B cell antigen receptor signaling: roles in cell development and disease. Science 2002. 296: 1641-1642.
42. Lowell, C. A., Src-family kinases: rheostats of immune cell signaling. Mol. Immunol. 2004. 41: 631-643.
43. Nishizumi, H., Horikawa, K., Mlinaric-Rascan, I. and Yamamoto, T., A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals. J. Exp. Med. 1998. 187: 1343-1348.
44. Ochi, H. and Watanabe, T., Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity. Int. Immunol. 2000. 12: 1417-1423.
45. Sen, G., Bikah, G., Venkataraman, C. and Bondada, S., Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Eur. J. Immunol. 1999. 29: 3319-3328.
46. Blery, M., Kubagawa, H., Chen, C. C., Vely, F., Cooper, M. D. and Vivier, E., The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc. Natl. Acad. Sci. USA 1998. 95: 2446-2451.
47. Yamashita, Y., Ono, M. and Takai, T., Inhibitory and stimulatory functions of paired Ig-like receptor (PIR) family in RBL-2H3 cells. J. Immunol. 1998. 161: 4042-4047.
48. Goodnow, C. C., Crosbie, J., Adelstein, S., Lavoie, T. B., Smith-Gill, S. J., Brink, R. A., Pritchard-Briscoe, H. et al., Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988. 334: 676-682.
49. Bygrave, A. E., Rose, K. L., Cortes-Hernandez, J., Warren, J., Rigby, R. J., Cook, H. T., Walport, M. J. et al., Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2004. 2: E243.
50. Chan, V. W., Meng, F., Soriano, P., DeFranco, A. L. and Lowell, C. A., Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 1997. 7: 69-81.
51. Allman, D., Lindsley, R. C., DeMuth, W., Rudd, K., Shinton, S. A. and Hardy, R. R., Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 2001. 167: 6834-6840.
52. Meade, J., Fernandez, C. and Turner, M., The tyrosine kinase Lyn is required for B cell development beyond the T1 stage in the spleen: rescue by over-expression of Bcl-2. Eur. J. Immunol. 2002. 32: 1029-1034.
53. Engel, P., Zhou, L. J., Ord, D. C., Sato, S., Koller, B. and Tedder, T. F., Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 1995. 3: 39-50.
54. Rickert, R. C., Rajewsky, K. and Roes, J., Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 1995. 376: 352-355.
55. Wang, J. H., Avitahl, N., Cariappa, A., Friedrich, C., Ikeda, T., Renold, A., Andrikopoulos, K. et al., Aiolos regulates B cell activation and maturation to effector state. Immunity 1998. 9: 543-553.
56. Martin, F., Oliver, A. M. and Kearney, J. F., Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001. 14: 617-629.
57. Ferry, H., Jones, M., Vaux, D. J., Roberts, I. S. and Cornall, R. J., The cellular location of self-antigen determines the positive and negative selection of autoreactive B cells. J. Exp. Med. 2003. 198: 1415-1425.